Innate Pharma S.A. (EPA:IPH)
France
· Delayed Price · Currency is EUR 1.576
-0.012 (-0.76%)
Jun 26, 2026, 5:35 PM CET
Innate Pharma Employees
Innate Pharma had 164 employees as of December 31, 2025. The number of employees decreased by 17 or -9.39% compared to the previous year.
Employees
164
Change (1Y)
-17
Growth (1Y)
-9.39%
Revenue / Employee
€54,909
Profits / Employee
€299,860
Market Cap
147.87M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Sensorion | 63 |
| Transgene | 145 |
| Valerio Therapeutics Société anonyme | 25 |
| Adocia | 73 |
| ABIONYX Pharma | 49 |
| OSE Immunotherapeutics | 64 |
| Valneva SE | 674 |
Innate Pharma News
- 5 weeks ago - Outcome of Innate Pharma's 2026 Annual General Meeting - Business Wire
- 5 weeks ago - Innate Pharma to participate in the Jefferies Global Healthcare Conference - Business Wire
- 6 weeks ago - Innate Pharma Q1 Earnings Call Highlights - MarketBeat
- 6 weeks ago - Innate Pharma Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Innate Pharma Earnings release: Q1 2026 - Filings
- 6 weeks ago - Innate Pharma Slides: Q1 2026 - Filings
- 6 weeks ago - Innate Pharma Earnings release: Q1 2026 - Filings
- 6 weeks ago - Innate Pharma Slides: Corporate presentation - Filings